-
Gowda invites LatAm, Caribbean countries to invest in India’s pharma sector
expresspharma
October 16, 2020
There is a need to convert common interest between Indian and Latin American/Caribbean countries into a successful model of cooperation.
-
Pfizer Foundation Invests in 20 Organizations Tackling Infectious Diseases and Antimicrobial Resistance
americanpharmaceuticalreview
August 22, 2019
The Pfizer Foundation has announced 20 grants to help non-governmental organizations (NGOs), non-profits and social enterprises address critical health challenges related to infectious diseases ...
-
CannaBiz Invest Asia to gather global cannabis industry players
biospectrumasia
July 20, 2019
Major cannabis product manufacturers will convene in Bangkok for a timely summit to share insights on this new market.
-
J&J to invest €100 million into Limerick manufacturing facilities creating 100 new jobs
pharmafile
May 17, 2019
Healthcare conglomerate Johnson & Johnson has said it will be investing €100 million into the expansion of its Vision Care manufacturing facilities in Limerick. The expansion is expected to see the creation of 100 new jobs.
-
Catalent Invests $14M at Germany Softgel Facility
contractpharma
April 24, 2019
Catalent has unveiled plans to expand integrated turnkey softgel capabilities at its facility in Eberbach, Germany.
-
Atlas Venture raises $250M for later-stage investments
fiercebiotech
January 04, 2019
Atlas Venture has raised $250 million to invest in existing portfolio companies. The fund, the first of its kind operated by Atlas, will enable the VC shop to support its startups through series B and beyond......
-
CX Partners acquires equity stake in Veeda Clinical Research
expressbpd
December 17, 2018
CX Partners acquires equity stake in Veeda Clinical Research
-
eHealth Ventures invests in disruptive diagnostic device
biospectrumasia
December 13, 2018
eHealth Ventures has invested $900,000 in the company's seed financing round.
-
GHIT Fund to invest $4.6M for new projects on drug development
biospectrumasia
December 13, 2018
Including the recent investment projects announcement, GHIT has invested approximately 14.1 billion yen ($124 million) in 77 global product development partnerships.
-
WuXi Biologics to invest $60 million for its first overseas site in U.S.
biospectrumasia
June 11, 2018
WuXi Biologics is a leading global platform company providing end-to-end solutions for biologics with a mission to accelerate and transform biologics discovery, development and manufacturing to benefit patients around the world.